NLS Pharmaceutics extends the maturity date of the loan

Nls Pharmaceutics Ltd (NLSP) has released an update.

NLS Pharmaceutics AG has extended the expiration date of its loan agreement with Ronald Hafner to June 30, 2025, retaining the original terms with an amendment effective May 13, 2024. The loan amount of CHF 500,000.00, together with any accrued interest, remains unchanged . while the parties consolidate their commitment under Swiss jurisdiction.

For more insight into NLSP stock, check out TipRanks’ Stock Analysis Page.